Arax Advisory Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.7K | Buy |
346
+32
| +10% | +$3.4K | ﹤0.01% | 1377 |
|
|
2025
Q1 | $39K | Buy |
314
+18
| +6% | +$2.24K | ﹤0.01% | 1045 |
|
|
2024
Q4 | $36.5K | Buy |
296
+13
| +5% | +$1.6K | ﹤0.01% | 991 |
|
|
2024
Q3 | $31.5K | Buy |
283
+212
| +299% | +$23.6K | ﹤0.01% | 900 |
|
|
2024
Q2 | $7.58K | Buy |
71
+1
| +1% | +$107 | ﹤0.01% | 1399 |
|
|
2024
Q1 | $8.43K | Hold |
70
| – | – | ﹤0.01% | 806 |
|
|
2023
Q4 | $8.61K | Hold |
70
| – | – | ﹤0.01% | 782 |
|
|
2023
Q3 | $9.06K | Hold |
70
| – | – | ﹤0.01% | 743 |
|
|
2023
Q2 | $8.68K | Hold |
70
| – | – | ﹤0.01% | 737 |
|
|
2023
Q1 | $10.2K | Hold |
70
| – | – | ﹤0.01% | 683 |
|
|
2022
Q4 | $11.2K | Hold |
70
| – | – | ﹤0.01% | 637 |
|
|
2022
Q3 | $9K | Hold |
70
| – | – | ﹤0.01% | 681 |
|
|
2022
Q2 | $11K | Hold |
70
| – | – | ﹤0.01% | 645 |
|
|
2022
Q1 | $11K | Hold |
70
| – | – | ﹤0.01% | 645 |
|
|
2021
Q4 | $9K | Hold |
70
| – | – | ﹤0.01% | 683 |
|
|
2021
Q3 | $9K | Buy |
+70
| New | +$9K | ﹤0.01% | 658 |
|
|
2020
Q4 | $1K | Sell |
6
-2
| -25% | -$333 | ﹤0.01% | 704 |
|
|
2020
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 663 |
|
|
2020
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 652 |
|
|
2020
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 649 |
|
|
2019
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 566 |
|
|
2019
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 568 |
|
|
2019
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 575 |
|
|
2018
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 543 |
|
|
2018
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 601 |
|